ON-bipolar cell gene expression during retinal degeneration: Implications for optogenetic visual restoration
0301 basic medicine
Retinal Bipolar Cells
Genetic Vectors
Retinal Degeneration
Mice, Transgenic
Inherited retinal degeneration
Dependovirus
Flow Cytometry
Real-Time Polymerase Chain Reaction
Immunohistochemistry
Spermidine Synthase
Article
3. Good health
Optogenetics
Mice
03 medical and health sciences
Gene Expression Regulation
Contactin 1
Animals
Annexin A7
Female
Gene expression
Bipolar cell
Sulfatases
DOI:
10.1016/j.exer.2021.108553
Publication Date:
2021-03-31T19:43:16Z
AUTHORS (8)
ABSTRACT
Retinal bipolar cells survive even in the later stages of inherited retinal degenerations (IRDs) and so are attractive targets for optogenetic approaches to vision restoration. However, it is not known what extent remodelling that these undergo during degeneration affects their function. Specifically, unclear if they free from metabolic stress, receptive adeno-associated viral vectors, suitable opsin-based tools able propagate signals by releasing neurotransmitter. Fluorescence activated cell sorting (FACS) was performed isolate labelled dissociated retinae litter-mates with or without IRD mutation Pde6brd1/rd1 selectively expressing an enhanced yellow fluorescent protein (EYFP) as a marker ON-bipolar cells. Subsequent mRNA extraction allowed Illumina® microarray comparison gene expression degenerate those wild type retinae. Changes four candidate genes were further investigated at level using immunohistochemistry over course degeneration. A total sixty differentially expressed transcripts reached statistical significance: did include any directly associated native primary signalling, nor changes consistent stress. Four significantly altered (Srm2, Slf2, Anxa7 & Cntn1), implicated synaptic remodelling, neurotransmitter release vector entry had immunohistochemical staining colocalising markers varying Our findings suggest relatively few context degeneration: despite likely remain viable In addition, several where seen could provide basis investigations enhance efficacy therapies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (68)
CITATIONS (20)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....